Patent details

EN | LT

LT - Farnezilproteintransferazės inhibitoriai, turintys radiosensibilizuojančių savybių (in vivo)

EN - FARNESYL PROTEIN TRANSFERASE INHIBITORS WITH (IN VIVO) RADIOSENSITIZING PROPERTIES

Legal status

Patent expired

Claims | Licences

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 41/00	(2006.01)
		A61P 35/00	(2006.01)

European patent
(11)	Number of the document	1094839
(13)	Kind of document	T
(96)	European patent application number	99931229.1
	Date of filing the European patent application	1999-06-30
(97)	Date of publication of the European application	2001-05-02
(45)	Date of publication and mention of the grant of the patent	2003-05-02
(46)	Date of publication of the claims translation	2003-09-25

PCT application
(86)	Number	PCT/EP9904/545
	Date	1999-06-30

PCT application publication
(87)	Number	WO 0000/1411
	Date	2000-01-13

Inventors
(72)	VAN GINCKEL, Robert Franciscus, BE FLOREN, Wim Joanna, Janssen Pharmaceutica N.V., BE END, David William, Janssen Research Foundation, US WOUTERS, Walter Boudewijn Leopold, BE

Grantee
(73)	Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, BE

Attorney or representative
(74)	Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT

Title
(54)	Farnezilproteintransferazės inhibitoriai, turintys radiosensibilizuojančių savybių (in vivo)
	FARNESYL PROTEIN TRANSFERASE INHIBITORS WITH (IN VIVO) RADIOSENSITIZING PROPERTIES

Last renewal fee
	Payment date	Validity (years)	Amount
	2018-05-22	20	347.00 EUR